| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
|
Cocorocchio, E.
|
|
|
22 |
10 |
p. 1818-1824
|
artikel
|
| 2 |
Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival
|
Sallabanda, M.
|
|
|
22 |
10 |
p. 1809-1817
|
artikel
|
| 3 |
Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm
|
Meattini, I.
|
|
|
22 |
10 |
p. 1698-1709
|
artikel
|
| 4 |
Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review
|
Baldini, E.
|
|
|
22 |
10 |
p. 1681-1686
|
artikel
|
| 5 |
Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients
|
Zhao, Z.
|
|
|
22 |
10 |
p. 1892-1906
|
artikel
|
| 6 |
Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics
|
Liu, D.
|
|
|
22 |
10 |
p. 1687-1697
|
artikel
|
| 7 |
Drug-metabolizing enzymes: role in drug resistance in cancer
|
Kaur, G.
|
|
|
22 |
10 |
p. 1667-1680
|
artikel
|
| 8 |
Effects of different doses of propofol on the growth and expression of PCNA, CD34 and pAKT proteins in xenografted tumor of BALB/C mice with liver cancer
|
Zhou, Q.
|
|
|
22 |
10 |
p. 1741-1749
|
artikel
|
| 9 |
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
|
Ciruelos, E.
|
|
|
22 |
10 |
p. 1857-1866
|
artikel
|
| 10 |
Exercise and cancer: a position statement from the Spanish Society of Medical Oncology
|
Pollán, M.
|
|
|
22 |
10 |
p. 1710-1729
|
artikel
|
| 11 |
Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer
|
Arroyo, M.
|
|
|
22 |
10 |
p. 1867-1874
|
artikel
|
| 12 |
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
|
Pérez-Ruiz, E.
|
|
|
22 |
10 |
p. 1778-1785
|
artikel
|
| 13 |
Letter to Editor regarding “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta‑analysis”
|
Rezaeeniya, F.
|
|
|
22 |
10 |
p. 1907
|
artikel
|
| 14 |
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks
|
Liang, M.
|
|
|
22 |
10 |
p. 1786-1795
|
artikel
|
| 15 |
Malignancies after renal transplantation: experience of a Mexican referral center
|
Leon-Rodriguez, E.
|
|
|
22 |
10 |
p. 1796-1801
|
artikel
|
| 16 |
Multifunctional nanocomposites MGO/FU-MI inhibit the proliferation of tumor cells and enhance the effect of chemoradiotherapy in vivo and in vitro
|
Peng, X.
|
|
|
22 |
10 |
p. 1875-1884
|
artikel
|
| 17 |
PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways
|
Feng, A. L.
|
|
|
22 |
10 |
p. 1838-1848
|
artikel
|
| 18 |
Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas
|
Viñal, D.
|
|
|
22 |
10 |
p. 1849-1856
|
artikel
|
| 19 |
Reply to: “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis”
|
Heydari, K.
|
|
|
22 |
10 |
p. 1908
|
artikel
|
| 20 |
RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo
|
Xu, G.
|
|
|
22 |
10 |
p. 1762-1777
|
artikel
|
| 21 |
Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial
|
Abdel-Rahman, O.
|
|
|
22 |
10 |
p. 1885-1891
|
artikel
|
| 22 |
THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition
|
Liu, X.
|
|
|
22 |
10 |
p. 1730-1740
|
artikel
|
| 23 |
The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials
|
Zhang, F.
|
|
|
22 |
10 |
p. 1750-1761
|
artikel
|
| 24 |
The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis
|
Heydari, K.
|
|
|
22 |
10 |
p. 1825-1837
|
artikel
|
| 25 |
VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions
|
La Rocca, E.
|
|
|
22 |
10 |
p. 1802-1808
|
artikel
|
Tijdschrift beschrijving